58 results about "Blood pressure control" patented technology

A system and method for regulating blood flow rate or blood pressure in a second blood vessel or heart chamber to achieve a balanced flow rate or blood pressure between the second blood vessel or heart chamber and a first blood vessel or heart chamber, wherein the first and the second blood vessels and heart chambers are on opposite sides of the circulatory system. The system comprises a monitor that monitors parameters indicative of a difference between the flow rates or blood pressures of the first and the second blood vessels or heart chambers. A regulator regulates the blood flow rate or blood pressure in at least a portion of the second blood vessel or heart chamber. A controller is configured to receive a signal from the monitor and to determine a difference between the flow rate or blood pressure of the first blood vessel or heart chamber and the flow rate or blood pressure of the second blood vessel or heart chamber. The controller determines a second blood flow rate or blood pressure in the second blood vessel or heart chamber that generates the balanced flow rate or blood pressure between the first and the second blood vessels or heart chambers. The controller then signals the regulator to generate the second determined blood flow rate or blood pressure in the at least portion of the lumen of the second blood vessel or heart chamber.

Hidden high blood pressure patients can not be identified by once blood pressure measuring, and the measuring is easily disturbed by emotion and motion states. In ideal blood pressure control, dynamic blood pressure in 24 hours needs to be monitored, the dynamic blood pressure has more advantages compared with the accidentally measured blood pressure, more blood pressure data can be obtained, the change rule of the blood pressure in the whole day can be practically reflected, and the measuring on the dynamic blood pressure has more meanings, and can be used for guiding pharmacy and predicting the seizure of cardiovascular diseases. The current domestic blood pressure monitor in the market is mainly mercurial and electronic blood pressure monitors, which are not convenient for the 24-hour blood pressure monitoring. For overcoming the defects, the invention provides the super-portable intelligent dynamic blood pressure detector, comprising a measuring unit and a smartphone; the measuring unit has no air pipe connection, adopts arm-type integral measuring, has no need of temporary mounting and is suitable for dynamic measuring; the smartphone is connected with the measuring unit by a wireless Bluetooth for transmitting a control command and receiving measuring data.

Devices and methods are disclosed to address blood pressure control. More particularly, the present invention relates to correction of transient low blood pressure.

The invention provides ganoderma noodles and a manufacturing method thereof. The ganoderma noodles are made from flour, prepared ganoderma powder, edible salt and dietary alkali. The ganoderma noodles are rich in nutrition, can improve the immunity through regular consumption, and have the functions of tumor resistance, aging resistance, blood pressure control, and the like. Compared with the prior art, the ganoderma noodles provided by the invention have no addition of gluten strengthening agents or other additives, however, have very good gluten degree and elasticity; and when the noodles are cooked, the noodles difficultly paste soup and have faint scent.

The invention discloses a compound medicine preparation for treating refractory hypertension, which is mainly prepared from the following components in parts by weight: 50 to 500 parts of ganoderan, 5 to 10 parts of nifedipine, 12.5 to 50 parts of captopril, 10 to 50 parts of hydrochlorothiazide and 12.5 to 100 parts of atenolol. According to the compound medicine preparation provided by the invention, the ganoderan is compounded with multiple antihypertensive drugs of conventional multiple-treatment to prepare a convenient-to-take compound preparation; the beneficial effects of synergetic antihypertensive effect and mutual side effect relieving/offsetting effect of the ganoderan and the four medicines are realized, the compliance of standardized medicine-taking of refractory hypertension patients is obviously improved, the therapeutic effect of obviously reducing the blood pressure level of the refractory hypertension or even realizing up-to-standard blood pressure control on part of the patients are achieved, and a novel convenient-to-take compound antihypertensive drug is provided for simplifying the drug use of the refractory hypertension patients and effectively reducing the blood pressure level.

The invention relates to compound blood pressure lowering capsules for treating metabolic hypertension, a preparation method and an application thereof, particularly to a preparation process of compound blood pressure lowering capsules for targeted treatments of various metabolic disorders of metabolic hypertension, wherein raw materials such as salvia miltiorrhiza bunge, obtuseleaf senna seed, cortex lycii, achyranthes bidentata blume, eucommia ulmoides and loranthus parasiticus are adopted, alcohol extraction is performed on the salvia miltiorrhiza bunge, the obtuseleaf senna seed, the cortex lycii and the achyranthes bidentata blume, the drug residue produced after alcohol extraction is added with the eucommia ulmoides and the loranthus parasiticus to carry out mixed water extraction, the alcohol extraction solution and the water extraction solution are subjected to concentration drying to prepare particles, and the particles are loaded into capsules so as to prepare the product Chinese patent medicine. According to the present invention, the compound blood pressure lowering capsules prepared by using the preparation process is designed based on various metabolic disorders of metabolic hypertension so as to stabilize the blood pressure, achieve blood sugar and blood fat metabolism, regulate metabolism, easily achieve blood pressure control, treat symptoms and root causes, and provide important significance for prevention and treatment of metabolic hypertension.

It is an object of the invention to improve a user's breathing for a specific application (e.g. diagnostic imaging, falling asleep improvement (shortening sleep onset), delivery, tinnitus control therapy, CORD, blood pressure control). This object is achieved by a breathing adaptation system configured for influencing a breathing parameter of a user's breathing pattern in order to meet a goal of decreasing or increasing the influenced breathing parameter to a certain extent in a user specific manner. The breathing adaptation system comprises a sensor, configured for monitoring a current value of the influenced breathing parameter of the user. The breathing adaptation system further comprises a feedback unit configured for providing feedback to the user about a preferred value of the influenced breathing parameter, wherein the preferred value is different from the current value of the influenced breathing parameter (310). The breathing adaptation system further comprises a control unit, comprising program code means for determining the preferred value of the influenced breathing parameter in a user specific manner by means of an intelligent agent, wherein the control unit is implemented such that the intelligent agent is rewarded (330) by means of a reward function after performing the determination of the preferred value (320) of the influenced breathing parameter, wherein the reward function is such that it balances the reward for obtaining the goal and the ability of the user to breathe according to a breathing pattern having the preferred value for the influenced breathing parameter.

A computer system and method is disclosed as a support structure for patients with hypertension or prehypertension to encourage life style changes leading to dietary control, increase exercise and blood pressure control. The method includes automated messages and responses delivered in real time to encourage appropriate actions by the patient. A diary feature is provided for user input of various relevant parameters, such as foods consumed, exercise activities, body weight, blood pressure, and heart rate. The computer system and method may be implemented on a mobile computing device, such as a smart phone or wearable, a conventional personal computer, or a web service. Most functions will be provided on the mobile device, but some housekeeping and data visualization functions may be limited to the personal computer or web service implementations.

The Laragh Method is a novel method useful for evaluating and treating hypertensive patients. The Laragh Method provides a systematic approach for the physician to use volume vasoconstriction information with entry and induced changes in blood pressure and in ambulatory plasma renin levels for the rational selection of treatment tailored to suit each individual hypertensive patient. The Laragh Method provides a systematic and rational approach to drug selection which greatly improves the therapeutic success rate among hypertensive patients and which for the large majority provides long-term blood pressure control with one drug instead of two or two instead of three with each drug rationally targeted to control the renin and/or volume elements in the blood pressure equation.

The invention relates to a home management method and system for hemodialysis patients based on an informatization technology. The method is characterized in that 1) a management system comprising a patient end, a medical care end and a server is arranged, and the medical care end is wirelessly connected with the patient end through the server or directly connected with the patient end to form a two-way communication loop; 2) the patient end carries out weight measurement reminding, blood pressure measurement reminding, water drinking reminding and medicine taking reminding at regular time so as to enable a patient to carry out weight measurement, blood pressure measurement, quantitative water drinking and quantitative medicine taking at regular time, and if the weight, the blood pressure and the water intake of the patient exceed limits, an alarm is given out; and 3) the medical care terminal monitors the body weight, blood pressure, water intake and medicine taking of the patient and performs health propaganda and education to guide the patient to control the body weight, measure the blood pressure, control the water intake and a medicine taking amount, and the medical care terminal transmits propaganda and education videos or documents to the patient terminal to supervise and urge the patient to conduct learning, observe the learning progress and perform examination reminding. The method and the device have the outstanding substantial characteristic and remarkable progress of capability of monitoring the body weight condition, the water drinking condition and the blood pressure control condition of the patient.

The illustrated embodiments include an apparatus having a programmable, implantable pacemaker with a controllable pacing rate; and a blood pressure monitoring device having an output communicated to the pacemaker. The pacemaker selectively and automatically modulates pacing rate in response to monitored blood pressure to reduce hypertensive blood pressure in a patient or treatment for DCHF (HPpEF). The embodiments also include a. method tor operating a pacing device to treat drug resistant hypertension which includes the steps of monitoring blood pressure; and controlling rate modulation in the pacing device in response to the monitored blood pressure to selectively prevent excessive pacing to reduce mean arterial blood pressure fay either inhibiting rate modulation in the pacing device or by changing rate modulation parameters.

The invention discloses a method and device for identifying hypertensive drug treatment price sensitivity. The method comprises the following steps: obtaining patient characteristic data and diagnosing patient characteristic data as primary hypertension through ICD-10, cleaning and desensitizing the characteristic data, and constructing a research queue; establishing a structured analysis data setby combining the research queue with patient follow-up visit data; taking patient cost input and blood pressure control as response targets, analyzing coupling and mapping relations of characteristicparameters of different research queues, and forming a price sensitivity calculation model; and generating a price sensitivity identification axis diagram, calibrating a working scale axis for each patient characteristic parameter, and performing numerical identification and cumulative conversion on the characteristic parameters through the working scale axis to obtain price sensitivity of different patients. The defect that an existing price sensitivity identification method depends on clinical experience is overcome, the price perception difference of multiple drug treatment schemes of a patient can be effectively solved, and reliable reference data is provided for formulating a reasonable drug use scheme for hypertension.

A computer system and method is disclosed as a support structure for patients with hypertension or prehypertension to encourage life style changes leading to dietary control, increase exercise and blood pressure control. The method includes automated messages and responses delivered in real time to encourage appropriate actions by the patient. A diary feature is provided for user input of various relevant parameters, such as foods consumed, exercise activities, body weight, blood pressure, and heart rate. The computer system and method may be implemented on a mobile computing device, such as a smart phone or wearable, a conventional personal computer, or a web service. Most functions will be provided on the mobile device, but some housekeeping and data visualization functions may be limited to the personal computer or web service implementations.

The invention discloses edible flour having blood pressure controlling effect and a production method of same. The edible flour includes a component A and a component B according to the ratio of A:B = 2/1 - 5/1. The component A particularly includes: wheat, corn, coix seeds, sorghum, mung beans, sweet potatoes, black sesame, buckwheat, polygonum multiflorum and kudzu roots; the component B particularly includes: chrysanthemum indicum, semen cassiae, bidens bipinnata, cornus officinalis, ilex pubesceus, codonopsis pilosula, hawthorns, Szechwan coptidis rhizome, prunella vulgaris, poria cocos, platycodon grandiflorum, radix bupleuri, pericarpium citri reticulatae, pinellia ternata, licorice roots, tails of angelica sinensis, longan, astragalus membranaceus, honeysuckles, and dendrobe. In the invention, a fine powder is prepared in a cell wall disruption manner, and pure natural traditional Chinese medicines are added, so that the edible flour has abundant nutrients and fine mouth feel and is easy to digest. Medicinal effects of the raw materials are completely remained, so that blood pressure and blood fat of human body are effectively controlled. The edible flour is suitable for people in high blood pressure, high blood glucose and high blood fat.